FDA Approves Orphan Drug Evinacumab-dgnb for Homozygous FH ...Middle East

Medscape - News
Indicated for homozygous familial hypercholesterolemia on top of other lipid-modifying therapy, Evkeeza (Regeneron) is a first-in-class inhibitor of a protein involved in lipid metabolism. Orphan Drug Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Orphan Drug Evinacumab-dgnb for Homozygous FH )

Apple Storegoogle play

Also on site :

Most viewed in News